View in EDS HTML Full Text PDF Full Text

Dual-antigen recognition iPSC-derived CAR-T cells for B-cell malignancies: establishment of a COVID-19 vaccine synergy strategy.

Saved in:
Bibliographic Details
Title: Dual-antigen recognition iPSC-derived CAR-T cells for B-cell malignancies: establishment of a COVID-19 vaccine synergy strategy.
Authors: Izumi N; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan., Furukawa Y; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan., Kinoshita S; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan., Ishii M; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan., Goto A; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan., Yasuda H; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan., Ando J; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.; Division of Cell Therapy and Blood Transfusion Medicine, Juntendo University School of Medicine, Tokyo, Japan., Nakauchi H; Stem Cell Therapy Division, Advanced Research Initiative, Institute of Science Tokyo, Tokyo, Japan.; Institute of Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, United States., Ando M; Department of Hematology, Juntendo University School of Medicine, Tokyo, Japan.
Source: Frontiers in cell and developmental biology [Front Cell Dev Biol] 2026 Feb 26; Vol. 14, pp. 1772146. Date of Electronic Publication: 2026 Feb 26 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101630250 Publication Model: eCollection Cited Medium: Print ISSN: 2296-634X (Print) Linking ISSN: 2296634X NLM ISO Abbreviation: Front Cell Dev Biol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2296-634X
DOI:10.3389/fcell.2026.1772146